Related Experiment Video
Updated: Apr 27, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Research progress on the anticarcinogenic actions and mechanisms of ellagic acid
Hong-Mei Zhang1, Lei Zhao1, Hao Li1
11 Medical Sciences Research Center, 2 Department of Pharmacy, The Second Affiliated Hospital of Southeast University, Nanjing 210003, China ; 3 Nanjing Longyuan Natural Polyphenol Synthesis Institute, Nanjing 210042, China.
Abstract:
Cancer is a leading cause of death worldwide. Cancer treatments by chemotherapeutic agents, surgery, and radiation have not been highly effective in reducing the incidence of cancers and increasing the survival rate of cancer patients. In recent years, plant-derived compounds have attracted considerable attention as alternative cancer remedies for enhancing cancer prevention and treatment because of their low toxicities, low costs, and low side effects. Ellagic acid (EA) is a natural phenolic constituent. Recent in vitro and in vivo experiments have revealed that EA elicits anticarcinogenic effects by inhibiting tumor cell proliferation, inducing apoptosis, breaking DNA binding to carcinogens, blocking virus infection, and disturbing inflammation, angiogenesis, and drug-resistance processes required for tumor growth and metastasis. This review enumerates the anticarcinogenic actions and mechanisms of EA. It also discusses future directions on the applications of EA.
Insights
Ellagic acid, a plant-derived compound, shows significant anticancer properties. It inhibits tumor growth and metastasis, offering a promising, low-toxicity alternative for cancer prevention and treatment.
Area of Science:
- Oncology
- Natural Products Chemistry
Background:
- Cancer remains a leading global cause of mortality.
- Conventional treatments like chemotherapy, surgery, and radiation have limitations in efficacy.
- Plant-derived compounds are emerging as potential alternatives due to low toxicity and cost.
Purpose of the Study:
- To review the anticarcinogenic actions and mechanisms of ellagic acid (EA).
- To explore EA as a potential alternative for cancer prevention and treatment.
- To discuss future applications of EA in oncology.
Main Methods:
- Review of recent in vitro and in vivo experimental studies on ellagic acid.
- Analysis of EA's effects on cancer cell proliferation, apoptosis, and DNA binding.
- Investigation of EA's impact on inflammation, angiogenesis, and drug resistance.
Main Results:
- Ellagic acid demonstrates broad anticarcinogenic effects.
- EA inhibits tumor cell proliferation and induces apoptosis.
- EA interferes with critical processes for tumor growth and metastasis, including DNA binding, inflammation, angiogenesis, and drug resistance.
Conclusions:
- Ellagic acid exhibits significant potential as an anticancer agent.
- EA's multifaceted mechanisms offer a promising avenue for novel cancer therapies.
- Further research into EA applications could enhance cancer prevention and treatment strategies.
More Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
Cancer Prevention
Some...

